🔴 Inovio Pharmaceuticals is trading 6.5% down today amid biotech-sector weakness

Inovio Pharmaceuticals is trading 6.49% down at $1.08, alongside weakness across the biotech sector.

• XBI fell about 2% in the session, offering context but not proof of a direct cause.
• No new company-specific explanation for the October 8 decline surfaced in available search results; the October 30 FDA decision date for INO-3107 was previously known.
• Reuters cited higher oil prices and Treasury yields as weighing on U.S. stocks.